No description
-
2021 (v1)PublicationUploaded on: April 14, 2023
-
2020 (v1)Publication
No description
Uploaded on: November 5, 2024 -
2018 (v1)Publication
No description
Uploaded on: March 27, 2023 -
2016 (v1)Publication
Background The HLA-DRB∗1501 haplotype influences the risk of developing multiple sclerosis (MS), but it is not known how it affects grey matter pathology. Aim To assess HLA-DRB∗1501 effects on magnetic resonance imaging (MRI) cortical grey matter pathology. Methods Whole and lesional cortical grey matter volumes, lesional and normal-appearing...
Uploaded on: April 14, 2023 -
2015 (v1)Publication
No description
Uploaded on: March 27, 2023 -
2015 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2024 (v1)Publication
: Progression independent of relapse activity (PIRA), a recent concept to formalize disability accrual in multiple sclerosis (MS) independent of relapses, has gained popularity as a potential clinical trial outcome. We discuss its shortcomings and appraise the challenges of implementing it in clinical settings, experimental trials, and...
Uploaded on: October 25, 2024